TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33413338

Group type: EXPERIMENTAL
Intervention: Professional identity formation-oriented intervention format (3 sessions in the first half for Group A)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Professional identity formation-oriented intervention format (3 sessions in the second half for Group B)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 112
Study: 32925342

Group type: EXPERIMENTAL
Intervention: Shoulder roll (2-inch vertical)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No shoulder roll
Number of subjects: 20
Study: 33517517

Group type: EXPERIMENTAL
Intervention: PSFON (point‐spread‐function modelling)
Number of subjects: 12

Group type: COMPARATOR
Intervention: PSFOFF (without point‐spread‐function modelling)
Number of subjects: 12
Study: 32632173

Group type: EXPERIMENTAL
Intervention: Lower limb loading (LLL) exercise with augmented loading feedback
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lower limb loading (LLL) exercise without augmented loading feedback
Number of subjects: 30
Study: 35125128

Group type: EXPERIMENTAL
Intervention: Nutrition and physical activity best practices
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nutrition self-efficacy
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Knowledge of food program best practices
Number of subjects: 49

Group type: COMPARATOR
Intervention: Self-efficacy in family style meal service
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nutrition and physical activity scores
Number of subjects: 49
Study: 34291444

Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention (Bobath concept)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no physiotherapy)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Number of physiotherapy sessions
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Home activities performed by parents
Number of subjects: 74
Study: 35810754

Group type: EXPERIMENTAL
Intervention: Zanubrutinib (group A) administered orally at 160 mg twice per day for 28-day cycles.
Number of subjects: 590

Group type: COMPARATOR
Intervention: Bendamustine-rituximab (group B) with bendamustine at 90 mg/m2 on days 1 and 2 for six cycles plus rituximab at 375 mg/m2 on day 1 of cycle 1 and 500 mg/m2 on day 1 of cycles 2–6, administered intravenously.
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Zanubrutinib (group C) for patients with del(17)(p13·1).
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Zanubrutinib (group A)
Number of subjects: 590

Group type: COMPARATOR
Intervention: Bendamustine-rituximab (group B)
Number of subjects: 590
Study: 33957649

Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream applied to the cervix weekly for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no treatment prior to LEEP)
Number of subjects: 90
Study: 32519431

Group type: EXPERIMENTAL
Intervention: Expectation intervention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 43
Study: 34454442

Group type: EXPERIMENTAL
Intervention: Gabapentin for 12 weeks
Number of subjects: 13
Study: 33021583

Group type: EXPERIMENTAL
Intervention: Quadrupedal Movement Training (QMT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 42
Study: 34048817

Group type: EXPERIMENTAL
Intervention: SF-SBRT 34 Gy
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: SF-SBRT 30 Gy
Number of subjects: 229
Study: 32299852

Group type: COMPARATOR
Intervention: PR only
Number of subjects: 34

Group type: COMPARATOR
Intervention: PR+SMS
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 34
Study: 33878154

Group type: EXPERIMENTAL
Intervention: Golimumab (GLM) 50 mg every 4 weeks during the OLE
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo (PBO) followed by Golimumab (GLM) 50 mg every 4 weeks during the OLE
Number of subjects: 198
Study: 35820904

Group type: EXPERIMENTAL
Intervention: Neuromuscular exercise intervention
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo laser needle acupuncture treatment
Number of subjects: 18
Study: 34282645

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) integrated with activity pacing for 6 sessions by a trained oncology nurse
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 58
Study: 32818112

Group type: EXPERIMENTAL
Intervention: Oral BI 1026706 100 mg twice daily for 12 weeks
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 105
Study: 34753304

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Endovascular treatment (EVT) in BASICS trial centers
Number of subjects: 264
Study: 32415231

Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy protocol based on Pivotal Response Treatment (PRT)
Number of subjects: 0
Study: 35452104

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody postexposure prophylaxis (PEP) with casirivimab and imdevimab
Number of subjects: 0

Group type: COMPARATOR
Intervention: No monoclonal antibody postexposure prophylaxis (PEP)
Number of subjects: 0
Study: 33937162

Group type: EXPERIMENTAL
Intervention: Removal of monthly attendance fees for full-day kindergartens
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Evidence generated from the RCT
Number of subjects: 236
Study: 32912410

Group type: EXPERIMENTAL
Intervention: Multimodal monitoring treatment group
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine monitoring treatment group
Number of subjects: 104
Study: 36056385

Group type: EXPERIMENTAL
Intervention: SMART cognitive rehabilitation programme
Number of subjects: 0
Study: 32593257

Group type: EXPERIMENTAL
Intervention: Standard therapy + audiovisual correction
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Standard therapy + audiovisual correction + testosterone undecanoate
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard therapy and escitalopram / tofisopam
Number of subjects: 89
Study: 34358777

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2, oral prednisone 5 mg twice daily, and oral enzalutamide 160 mg/d (arm DE)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m2 and oral prednisone 5 mg twice daily (arm D)
Number of subjects: 246
Study: 33463883

Group type: EXPERIMENTAL
Intervention: Purchasing pesticides for self-poisoning (cases)
Number of subjects: 250
Study: 36457354

Group type: EXPERIMENTAL
Intervention: Abdominal Functional Electrical Stimulation (FES)
Number of subjects: 80
Study: 34614266

Group type: EXPERIMENTAL
Intervention: 60% oxygen
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 54
Study: 35640438

Group type: EXPERIMENTAL
Intervention: Kegel exercise
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Lubricant gel
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 34871892

Group type: EXPERIMENTAL
Intervention: Forward Walking on Sand (SG)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Backward Walking on Sand (SG)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Forward Walking on Overground (OG)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Backward Walking on Overground (OG)
Number of subjects: 28
Study: 32204151

Group type: EXPERIMENTAL
Intervention: Knowledge acquired from teachers about menstruation and cleaning menstrual pads
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Negative thoughts and fears related to menstrual hygiene
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Myths and beliefs about menstruation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Emotional responses related to menstrual self hygiene
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Psychosocial and physical disadvantages
Number of subjects: 6
Study: 34033270

Group type: EXPERIMENTAL
Intervention: Prazosin, uptitrated to 16 mg/d
Number of subjects: 100
Study: 33065103

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control (no ivermectin)
Number of subjects: 280
Study: 34489350

Group type: EXPERIMENTAL
Intervention: Personal Protective Equipment (PPE)
Number of subjects: 48
Study: 33214044

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) to prostate and pelvis, dose delivered was 35–37.5 Gy to prostate and gross node, 25 Gy in five fractions to elective pelvic nodal region.
Number of subjects: 60
Study: 35838816

Group type: EXPERIMENTAL
Intervention: BPEC (Behavioral Parent Emotion Coaching)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 119
Study: 33347530

Group type: EXPERIMENTAL
Intervention: injectable platelet‐rich fibrin (i‐PRF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no i‐PRF)
Number of subjects: 40
Study: 35626906

Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 113

Group type: COMPARATOR
Intervention: Photo group
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 113
Study: 32084505

Group type: EXPERIMENTAL
Intervention: Testosterone administration
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 62
Study: 35301388

Group type: EXPERIMENTAL
Intervention: high-definition tRNS
Number of subjects: 61

Group type: COMPARATOR
Intervention: simple-definition tRNS
Number of subjects: 61

Group type: COMPARATOR
Intervention: sham
Number of subjects: 61
Study: 33999161

Group type: EXPERIMENTAL
Intervention: 0 vs 6 months of androgen deprivation therapy (ADT) with external beam radiotherapy in DFCI 95‐096 trial
Number of subjects: 1173

Group type: EXPERIMENTAL
Intervention: 6 vs 36 months of ADT with external beam radiotherapy in EORTC 22961 trial
Number of subjects: 1173

Group type: COMPARATOR
Intervention: PSA failure in EORTC 22961
Number of subjects: 1173
Study: 32555938

Group type: EXPERIMENTAL
Intervention: Silicone foam implants (Lifesil®)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Microtexturized silicone implants (Lifesil®)
Number of subjects: 58
Study: 36213584

Group type: EXPERIMENTAL
Intervention: Breathing exercises
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Breathing exercises combined with acupuncture therapy
Number of subjects: 500
Study: 33360345

Group type: EXPERIMENTAL
Intervention: SMDS combined with aspirin
Number of subjects: 135
Study: 32163097

Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC 5) plus Pemetrexed (500 mg/m2) followed by maintenance Pemetrexed (500 mg/m2) every 3 weeks
Number of subjects: 433

Group type: COMPARATOR
Intervention: Docetaxel monotherapy (60 mg/m2) every 3 weeks
Number of subjects: 433
Study: 35514254

Group type: COMPARATOR
Intervention: Test linagliptin formulation (5 mg) under fasting conditions
Number of subjects: 84

Group type: COMPARATOR
Intervention: Reference linagliptin formulation (5 mg) under fasting conditions
Number of subjects: 84

Group type: COMPARATOR
Intervention: Test linagliptin formulation (5 mg) under fed conditions
Number of subjects: 84

Group type: COMPARATOR
Intervention: Reference linagliptin formulation (5 mg) under fed conditions
Number of subjects: 84
Study: 34795270

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (including vitamins, iron, and zinc)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (including vitamins and iron)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation
Number of subjects: 80
Study: 34348455

Group type: EXPERIMENTAL
Intervention: Clofarabine 5x40 mg/m2 + PEG-ASP 2,500 IU/m2
Number of subjects: 143

Group type: COMPARATOR
Intervention: High-dose cytarabine (HIDAC) 4x3g/m2 + PEG-ASP 2,500 IU/m2
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Clofarabine + PEG-ASP
Number of subjects: 143

Group type: COMPARATOR
Intervention: High-dose cytarabine + PEG-ASP
Number of subjects: 143
Study: 34245010

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 6380

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 6380

Group type: EXPERIMENTAL
Intervention: Optimal ASM selection
Number of subjects: 6380
Study: 33374768

Group type: EXPERIMENTAL
Intervention: HBV vaccination uptake
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: anti-HBc positivity
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Sharps injuries (SIs)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Emergency procedure exposures
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Ambulance exposures
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Hollow-bore needle injuries
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Unreported SIs
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Needle recapping
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Safety engineered devices (SEDs) usage
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Knowledge score
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Infection-control training participation
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Risk of SIs for untrained paramedics
Number of subjects: 286
Study: 36092992

Group type: EXPERIMENTAL
Intervention: Z-GROW coaching intervention
Number of subjects: 109

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 109
Study: 33269553

Group type: EXPERIMENTAL
Intervention: High-Flow Oxygen Therapy (HFT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Noninvasive Ventilation (NIV)
Number of subjects: 30
Study: 36471595

Group type: EXPERIMENTAL
Intervention: PRD + KAA (42 patients)
Number of subjects: 79

Group type: COMPARATOR
Intervention: PRD (37 patients)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: PRD + KAA
Number of subjects: 79
Study: 33353412

Group type: EXPERIMENTAL
Intervention: Web-based tanning behavior change intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32979314

Group type: EXPERIMENTAL
Intervention: WONDFO SARS-CoV-2 Antibody Test (Wondfo Biotech, Guangzhou, China)
Number of subjects: 56000
Study: 35029220

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study: 33079445

Group type: EXPERIMENTAL
Intervention: GPIbα (instrumented by cis-pQTL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPIbα (instrumented by trans-pQTL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platelet count
Number of subjects: 0

Group type: COMPARATOR
Intervention: GPIbα (cis-pQTL)
Number of subjects: 0
Study: 36897521

Group type: EXPERIMENTAL
Intervention: Ezetimibe/Rosuvastatin fixed dose combination (10 mg/10 mg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Individual formulations (Ezetimibe and Rosuvastatin)
Number of subjects: 68
Study: 33665879

Group type: EXPERIMENTAL
Intervention: Negative wealth shock
Number of subjects: 0

Group type: COMPARATOR
Intervention: Marginal structural models (MSM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Principal stratification (PS)
Number of subjects: 0
Study: 33800281

Group type: EXPERIMENTAL
Intervention: Long‐term Innovative Follow‐up Extension (LIFE) component
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: REB approval process
Number of subjects: 140
Study: 33285100

Group type: EXPERIMENTAL
Intervention: Laminaria
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Dilapan-S
Number of subjects: 67
Study: 32414405

Group type: EXPERIMENTAL
Intervention: Enhanced quarterly counseling on HIV risk reduction, couple communication, family planning and nutrition delivered by study counselors through up to 24 months postpartum
Number of subjects: 1230

Group type: COMPARATOR
Intervention: Standard post-test counseling
Number of subjects: 1230
Study: 33549133

Group type: EXPERIMENTAL
Intervention: Robotic natural orifice specimen extraction surgery (NOSES)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Traditional robotic-assisted surgery
Number of subjects: 550
Study: 33477143

Group type: EXPERIMENTAL
Intervention: Point of care ultrasonography (POCUS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combinational ultrasound evaluation
Number of subjects: 0
Study: 32248857

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (8-week duration, incorporated into the standard falls prevention class)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard falls prevention class (control group)
Number of subjects: 22
Study: 36223865

Group type: EXPERIMENTAL
Intervention: Health red-meat-reduction message
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Environmental red-meat-reduction message
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Animal welfare red-meat-reduction message
Number of subjects: 2773

Group type: COMPARATOR
Intervention: Control message (neutral, non-red meat message)
Number of subjects: 2773
Study: 35655482

Group type: EXPERIMENTAL
Intervention: 10 Hz binaural beats
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Short-term training
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Aging and reduced sound intervention volume
Number of subjects: 31
Study: 32301407

Group type: EXPERIMENTAL
Intervention: Cranberry beverage (450 ml daily for 8 weeks)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Cranberry beverage
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 35708621

Group type: EXPERIMENTAL
Intervention: In-class nutrition education with in-class feeding content
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: In-class nutrition education with online feeding content
Number of subjects: 382

Group type: COMPARATOR
Intervention: In-class nutrition education only
Number of subjects: 382
Study: 33419890

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 346

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 346
Study: 32387531

Group type: EXPERIMENTAL
Intervention: Condition with calorie information presented relative to the highest calorie item
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Condition with calorie information presented relative to the lowest calorie item
Number of subjects: 633

Group type: COMPARATOR
Intervention: Condition with per-item calorie information
Number of subjects: 633

Group type: COMPARATOR
Intervention: No calorie information (control condition)
Number of subjects: 633
Study: 35124320

Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy (ET)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 178
Study: 33221186

Group type: COMPARATOR
Intervention: Violence Prevention Program (VPP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Positive Youth Development Program (PYDP)
Number of subjects: 100
Study: 32049861

Group type: EXPERIMENTAL
Intervention: Intrauterine double-balloon catheter
Number of subjects: 224

Group type: COMPARATOR
Intervention: Gauze packing
Number of subjects: 224
Study: 35206481

Group type: EXPERIMENTAL
Intervention: Yes VR group (VR analgesia)
Number of subjects: 82

Group type: COMPARATOR
Intervention: No VR group (non‐medical conversation)
Number of subjects: 82
Study: 34384855

Group type: COMPARATOR
Intervention: Expiration Breath Hold (EBH)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Deep Inspiration Breath Hold (DIBH)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Inspiration Breath Hold (IBH)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Personalized technique
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Personalized technique (not EBH)
Number of subjects: 18
Study: 32819350

Group type: EXPERIMENTAL
Intervention: Continuous Aerobic Exercise Program (CAEP)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 35796392

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 800 mcg/day intranasally for 12 weeks
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Prednisone 0.5 mg/kg/day orally for 7 days, followed by a decreasing dosage for another week
Number of subjects: 92

Group type: COMPARATOR
Intervention: Systemic steroid therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Intranasal steroid therapy
Number of subjects: 92
Study: 33466246

Group type: COMPARATOR
Intervention: AB Serum (ABS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Mesenchymal stromal cells (STx.)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cells in hyaluronic acid (HA + STx.)
Number of subjects: 28
Study: 36149968

Group type: EXPERIMENTAL
Intervention: Lisocabtagene maraleucel (liso-cel)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 90
Study: 34369698

Group type: EXPERIMENTAL
Intervention: Acupuncture of Tiaoren Tongdu (applied to specific acupuncture points, needles retained for 30 min, treatment once every other day, 3 times a week for 8 weeks)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Non-acupuncture group (psychotherapy, once daily for 8 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Acupuncture B group (less than 6 treatments)
Number of subjects: 116
Study: 35101364

Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab plus metronomic chemotherapy (TPM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pertuzumab plus trastuzumab (TP)
Number of subjects: 80
Study: 34391982

Group type: EXPERIMENTAL
Intervention: PCEA
Number of subjects: 317

Group type: COMPARATOR
Intervention: PCEA + PIEB
Number of subjects: 317
Study: 32653606

Group type: EXPERIMENTAL
Intervention: 50 mg of mifepristone every other day for two months followed by insertion of an LNG-IUS 52 mg
Number of subjects: 58

Group type: COMPARATOR
Intervention: Comparator (not specified)
Number of subjects: 58
Study: 33196290

Group type: EXPERIMENTAL
Intervention: Microbial phytase (0, 500, and 2000 FTU/kg)
Number of subjects: 48
Study: 32930855

Group type: EXPERIMENTAL
Intervention: Ring curettage
Number of subjects: 347

Group type: COMPARATOR
Intervention: 3D histologically controlled surgery
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Curettage
Number of subjects: 347
Study: 36387992

Group type: EXPERIMENTAL
Intervention: 3 60‐min sessions of Brief Prolonged Exposure Therapy (Brief PE)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 200
Study: 33431162

Group type: EXPERIMENTAL
Intervention: Retrievable inferior vena cava filter (rIVCF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No rIVCF (Control)
Number of subjects: 42